Viscosupplementation for knee osteoarthritis
- 1 March 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Association of Nurse Practitioners
- Vol. 26 (3) , 163-175
Abstract
Purpose: To provide an overview of the diagnosis and pathophysiology of osteoarthritis (OA), and to describe appropriate treatments for knee OA, with a focus on the efficacy and safety of viscosupplementation. Because nurse practitioners (NPs) can inject viscosupplements, a section on injection technique is included. Data sources: Manuscripts were identified using PubMed and EMBASE with a review of the reference lists from retrieved articles. Conclusions: Viscosupplements are safe and effective at improving function and alleviating knee pain from OA for up to 26 weeks. Implications for practice: As the number of patients with OA is increasing, NPs need to be prepared to prescribe various treatment options to alleviate osteoarthritic knee pain, including viscosupplementation.Keywords
This publication has 43 references indexed in Scilit:
- Accuracy of blind versus ultrasound‐guided suprapatellar bursal injectionJournal of Clinical Ultrasound, 2011
- Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX TrialOsteoarthritis and Cartilage, 2011
- Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trialAnnals of the Rheumatic Diseases, 2010
- Functional Improvement with Hylan G-F 20 in Patients with Knee OsteoarthritisThe Physician and Sportsmedicine, 2009
- A Double-Blind, Randomized, Saline-Controlled Study of the Efficacy and Safety of EUFLEXXA® for Treatment of Painful Osteoarthritis of the Knee, With an Open-Label Safety Extension (The FLEXX Trial)Seminars in Arthritis and Rheumatism, 2009
- Viscosupplementation: Managed Care Issues for Osteoarthritis of the KneeJournal of Managed Care Pharmacy, 2007
- Use of Nonsteroidal Antiinflammatory DrugsCirculation, 2007
- The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT–OARSIOsteoarthritis and Cartilage, 2005
- Efficacy and Safety of Intraarticular Sodium Hyaluronate in Knee OsteoarthritisClinical Orthopaedics and Related Research, 2001
- The role of viscosupplementation with hylan G-F 20 (Synvisc®) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs aloneOsteoarthritis and Cartilage, 1995